Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation-Reference-Cited by-同舟云学术

Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation

Published:2012-10 Issue:7420 Volume:490 Page:412-416
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Landsberg Jennifer,Kohlmeyer Judith,Renn Marcel,Bald Tobias,Rogava Meri,Cron Mira,Fatho Martina,Lennerz Volker,Wölfel Thomas,Hölzel Michael,Tüting Thomas

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature11538.pdf

Reference43 articles.

1. Restifo, N. P., Dudley, M. E. & Rosenberg, S. A. Adoptive immunotherapy for cancer: harnessing the T cell response. Nature Rev. Immunol. 12, 269–281 (2012)

2. Rosenberg, S. A. et al. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin. Cancer Res. 17, 4550–4557 (2011)

3. Khong, H. T. & Restifo, N. P. Natural selection of tumor variants in the generation of “tumor escape” phenotypes. Nature Immunol. 3, 999–1005 (2002)

4. Matsushita, H. et al. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature 482, 400–404 (2012)

5. DuPage, M., Mazumdar, C., Schmidt, L. M., Cheung, A. F. & Jacks, T. Expression of tumour-specific antigens underlies cancer immunoediting. Nature 482, 405–409 (2012)

Cited by 518 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of tubulin β-3 and 5 hydroxy-methyl cytosine as diagnostic and prognostic markers in malignant melanoma;Annals of Diagnostic Pathology;2024-10

2. Key characteristics of carcinogens meet hallmarks for prevention-cutting the Gordian knot;Frontiers in Oncology;2024-09-10

3. Cancer drug-tolerant persister cells: from biological questions to clinical opportunities;Nature Reviews Cancer;2024-09-02

4. Single-cell RNA sequencing reveals melanoma cell state-dependent heterogeneity of response to MAPK inhibitors;eBioMedicine;2024-09

5. Unveiling the Dynamic Interplay between Cancer Stem Cells and the Tumor Microenvironment in Melanoma: Implications for Novel Therapeutic Strategies;Cancers;2024-08-16